15 Results
Following the earnings announcement, WBA will hold a Virtual Investor Conference hosted by the company’s global leadership team.
Company deploying proceeds of $6.5 billion to pay down debt and boost strategic healthcare investments Extended and expanded commercial agreements to drive incremental growth and synergies
WBA announced the early results and upsizing of the previously announced cash tender offer.
WBA announced the pricing terms of the previously announced cash tender offer for certain outstanding senior notes.
WBA launches tender offer to purchase certain outstanding debt.
Walgreens Boots Alliance announced that its board of directors has declared a quarterly dividend of 46.75 cents per share.
Co-Chief Operating Officer Alex Gourlay and Executive Vice President and Global Chief Financial Officer James Kehoe will participate at the J.P. Morgan Healthcare Conference on Wednesday, Jan. 13.
WBA co-COO Alex Gourlay and CFO James Kehoe will participate at the 2nd Annual Wolfe Research Healthcare Conference on Nov. 19.
WBA has appointed Valerie Jarrett to its board of directors. She joins as an independent director and becomes the board’s eleventh member.
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the pricing of an underwritten public offering of unsecured, unsubordinated notes.
